Sankyo signs up Singapore pharma for natural product leads
Thursday, 21 April, 2005
Private Singapore natural products company MerLion Pharmaceuticals has sealed a three-year cooperative drug discovery and development collaboration with Japan's Sankyo.
The companies will collaborate on both the lead discovery and optimisation stages of the collaboration. Sankyo will provide selected high-throughput screens and additional assays to MerLion, which will provide access to its sample collection. Sankyo will undertake clinical development and commercialisation of the discoveries.
Common arthritis drug also lowers blood pressure
Scientists have known for a while that methotrexate helps with inflammation, but it may also help...
AI enables precise gene editing
A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
